In response to market demands and customer requests our new product development team are currently developing antibodies and antigens for:
- Zika (coming soon)
Having a combined team of antibody and assay development specialists allows BBI to select antibodies from a large pool of candidates screened with IVD customer applications in mind. All antibodies developed by BBI Solutions are produced in-house under cGMP conditions for long-term security of supply.
- FABP (Heart)
- HIV-1 p24
- Human TPO
- Troponin I, Troponin T, Troponin C